Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.21.2
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Operating expenses:        
Research and development $ 2,467,575 $ 11,543,973 $ 5,728,479 $ 15,256,652
General and administrative 1,370,393 808,333 3,346,969 2,327,416
Total operating expenses 3,837,968 12,352,306 9,075,448 17,584,068
Loss from operations (3,837,968) (12,352,306) (9,075,448) (17,584,068)
Other income (expense):        
Interest income 24,254 16,495 44,287 61,010
Interest expense (1,033) (885) (3,601) (2,593)
Local business tax (600) (600) (1,200) (1,200)
Miscellaneous income 670 1,795
Total other income, net 22,621 15,010 40,156 59,012
Loss before income taxes (3,815,347) (12,337,296) (9,035,292) (17,525,056)
Income tax benefit
Net loss $ (3,815,347) $ (12,337,296) $ (9,035,292) $ (17,525,056)
Basic and diluted net loss per share $ (0.03) $ (0.24) $ (0.08) $ (0.36)
Shares used to compute basic and diluted net loss per share 115,864,162 52,222,473 109,357,191 49,173,638